Лучшие доктора по химиотерапии при лейкозе в Китае – ТОП-4 доктора

Ху Кай специализируется на химиотерапии лейкоза с упором на иммунотерапию и биомаркеры, придерживаясь международных стандартов лечения.

• Член нескольких престижных комитетов по гематологии и онкологии в Китае
• Проводит исследования в области иммунотерапии и биомаркеров рака крови
• Участвует в более чем 20 международных и национальных клинических исследованиях
• Эксперт в комплексном стандартизированном лечении, включая трансплантацию стволовых клеток

Dr. Lu Peihua is a U.S. and China-licensed hematology and oncology expert and a pioneer in cell immunotherapy. After graduating from Beijing Medical University, she trained in the U.S. and completed a clinical fellowship at Stanford University, later receiving two prestigious NIH awards. She was among the first to introduce Cytokine-Induced Killer (CIK) cell therapy in China. Since returning to China in 2015, she has led advancements in CAR-T therapy and hematologic cancer treatment. Dr. Lu holds leadership roles in more than 10 medical organizations, including Chair of the Hematology Committee under the Chinese Non-Public Medical Institutions Association. She has been honored with national awards such as the "Medical Management Award" and "People's Doctor of the Year."
 

Department: General Hematology, Lymphoma&Myeloma Center

Biography

Dr. Zhou Daobin is a chief physician and doctoral advisor, formerly Head of Hematology at Peking Union Medical College Hospital. He specializes in hematologic malignancies and stem cell transplantation. Dr. Zhou has served as Chairman of the Beijing Hematology Association, Vice President of the Chinese Medical Doctor Association Hematology Branch, and is a standing member in multiple national academic committees. He is also an editorial board member for key journals such as Chinese Journal of Hematology and Clinical Hematology Journal.
 

Department: Lymphoma & Myeloma Center